(Q61917395)
Statements
A Prospective, Single Center, Open-Label, Dose-Escalation Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Treatment Naïve Or Resistant Cases Of Visceral Leishmaniasis (Kala-Azar). (English)
0 references
February 2007
0 references
July 2008
0 references
60
0 references
18 year
0 references
65 year
0 references